Amphetamine-Dextroamphetamine-Induced Cardiomyopathy: A Case Report on Heart Failure in a Young Addict.
| Autor: | Al-Juhani A; Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU., Alyaseen EM; College of Medicine and Medical Science, Arabian Gulf University, Manama, BHR., Aseri S; Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU., Alghamdi OM; Cardiology, Althager General Hospital, Jeddah, SAU. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2024 Oct 07; Vol. 16 (10), pp. e71044. Date of Electronic Publication: 2024 Oct 07 (Print Publication: 2024). |
| DOI: | 10.7759/cureus.71044 |
| Abstrakt: | In teenagers and young adults, dextroamphetamine-induced cardiomyopathy is becoming a more common cause of heart failure. More patients are at risk of this cardiac manifestation due to the medication's increased use in the treatment of attention-deficit/hyperactivity disorder (ADHD), particularly those who are unaware of the risks associated with using it improperly to improve concentration for poor performance. It becomes imperative to draw attention to the link between heart failure and amphetamine-dextroamphetamine usage to raise awareness of this illness. This case study revolves around a 32-year-old man with a complicated medical history who was recently diagnosed with heart failure with reduced ejection fraction (HFrEF < 10%), which was linked to amphetamine-induced cardiomyopathy. His recent diagnosis of ADHD and the treatment that followed raise questions regarding the potential for drug-induced worsening of underlying cardiomyopathy. To address his cardiac and concomitant issues, the patient is currently on a complete pharmaceutical regimen that includes atorvastatin, aspirin, furosemide, spironolactone, enoxaparin, omeprazole, and carvedilol. To maximize results and stop additional cardiac deterioration, patients with dual diagnoses, especially those involving amphetamine use and preexisting cardiac conditions, need to be carefully monitored and managed by a multidisciplinary team. Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. (Copyright © 2024, Al-Juhani et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|